FindTrial
Sign In

Role of lower genital infection in persistence of Human Papiloma virus infection in women

Role of cervico vaginal microbiome in persistence of high risk HPV infection in women attending gynaecology out patient department in a tertiary hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/03/018191
Enrollment
385
Registered
2019-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

None listed

Sponsors

Rajiv Gandhi Institute of Health Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women attending Gynacology opd

Exclusion criteria

Exclusion criteria: Women on active treatment for pelvic inflammatory disease, abnormal uterine bleeding, tuberculosis, HIV positive, uterovaginal prolapse, post hysterectomy, past history of cryotherapy or other cervical transformation zone excision procedures, any malignancies being treated or to be treated .

Design outcomes

Primary

MeasureTime frame
1 To identify women with hrHPV(high risk human papilloma virus) by using the hrHPV (high risk human papilloma virus) testing. 2 To study the patterns and association of cervicovaginal microbiome in the development of hrHPV infection. Timepoint: 6-12 months recruitment next 12 months follow up. total duration 2 years—

Secondary

MeasureTime frame
If chronic cervicitis is associated with persistence of HPV then treatment of chronic cervicits should reduce cervical cancerTimepoint: 2 years—

Countries

India

Contacts

Public ContactDr Shakuntala PN

ESIC PGIMSR and MC

shakuntala_pn@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026